63940-1
Hormone treatment for cancer
Active
Fully-Specified Name
- Component
- Hormone treatment for cancer
- Property
- Type
- Time
- Pt
- System
- ^Patient
- Scale
- Nom
- Method
Additional Names
- Short Name
- Hormone Rx for cancer
Survey Question
- Text
- Name of hormone therapy?
- Source
- PX071101020702
Example Answer List: LL1126-3
Source: Consensus measures for Phenotypes and Exposures| Answer | Code | Score | Answer ID |
|---|---|---|---|
| TamoxifenCopyright http://snomed.info/sct ID:373345002 Tamoxifen (substance) | 1 | LA14344-8 | |
| Aromasin® | 2 | LA14342-2 | |
| Femara® | 3 | LA14343-0 | |
| Other | 4 | LA46-8 |
Basic Attributes
- Class
- H&P.HX
- Type
- Clinical
- First Released
- Version 2.36
- Last Updated
- Version 2.66
- Change Reason
- Updated the PhenX ID from "PhenX.<ID>" to "PX<ID>" in Survey Question Source field to align with the variable identifier used in the PhenX Toolkit.; Updated Component and Property to align with existing terms for hormone treatment. To promote use of this concept for various use-cases, removed method of PhenX, updated Class from PhenX to H&P.HX, and update Answer List Type from NORMATIVE to EXAMPLE. Added Answer list and Answer List Type in the instance of the panel for the PhenX protocol.
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 62557-4 | PhenX domain - Cancer |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| es-MX | Spanish (Mexico) | Tratamiento hormonal para el cáncer: |
| it-IT | Italian (Italy) | Terapia ormonale per cancro: Synonyms: Anamnesi paziente Punto nel tempo (episodio) |
| zh-CN | Chinese (China) | 癌症的激素治疗: Synonyms: 分类型应答; |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=63940-1
Third Party Copyright
This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO) under license. All rights reserved. SNOMED CT® was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO.
This material includes content from the US Edition to SNOMED CT, which is developed and maintained by the U.S. National Library of Medicine and is available to authorized UMLS Metathesaurus Licensees from the UTS Downloads site at https://uts.nlm.nih.gov.
Use of SNOMED CT content is subject to the terms and conditions set forth in the SNOMED CT Affiliate License Agreement. It is the responsibility of those implementing this product to ensure they are appropriately licensed and for more information on the license, including how to register as an Affiliate Licensee, please refer to http://www.snomed.org/snomed-ct/get-snomed-ct or info@snomed.org<mailto:info@snomed.org>. This may incur a fee in SNOMED International non-Member countries.
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright